(PHM) PulteGroup - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US7458671010
Stock: Single-Family, Townhome, Condo, Land, Financing, Title
Total Rating 50
Risk 73
Buy Signal 0.16
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.80% |
| Yield on Cost 5y | 1.96% |
| Yield CAGR 5y | 12.71% |
| Payout Consistency | 83.5% |
| Payout Ratio | 8.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 33.4% |
| Relative Tail Risk | -7.84% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.66 |
| Alpha | 10.02 |
| Character TTM | |
|---|---|
| Beta | 0.710 |
| Beta Downside | 0.424 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.01% |
| CAGR/Max DD | 0.94 |
Description: PHM PulteGroup December 17, 2025
PulteGroup, Inc. (NYSE:PHM) is a U.S. homebuilder that acquires, develops, and constructs residential properties across multiple segments-including single-family homes, townhomes, condos, and duplexes-under brands such as Pulte Homes, Centex, Del Webb, and others. The firm also offers ancillary services like mortgage origination, loan-servicing rights sales, title insurance, and closing services, creating a vertically integrated business model. Founded in 1950 and headquartered in Atlanta, Georgia, PulteGroup operates primarily in the homebuilding sub-industry of the Consumer Discretionary sector.
Key recent metrics: FY 2023 revenue was approximately $8.2 billion with a net profit margin of ~6.5%; the company reported a backlog of roughly $12 billion, indicating strong future demand. Core drivers include the U.S. housing-starts cycle, mortgage-rate volatility (currently around 6.5% for a 30-year fixed), and regional labor-cost pressures that affect construction margins. The broader homebuilding sector remains sensitive to consumer confidence and inventory-to-sales ratios, which have been tightening as new-home supply lags demand.
For a deeper, data-driven view of PHM’s valuation dynamics, you may find ValueRay’s analytical dashboards worth exploring.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 2.22b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 0.44 > 1.0 |
| NWC/Revenue: 69.52% < 20% (prev 73.29%; Δ -3.77% < -1%) |
| CFO/TA 0.10 > 3% & CFO 1.83b > Net Income 2.22b |
| Net Debt (154.7m) to EBITDA (3.02b): 0.05 < 3 |
| Current Ratio: 5.15 > 1.5 & < 3 |
| Outstanding Shares: last quarter (195.8m) vs 12m ago -5.04% < -2% |
| Gross Margin: 26.75% > 18% (prev 0.29%; Δ 2646 % > 0.5%) |
| Asset Turnover: 97.77% > 50% (prev 103.4%; Δ -5.58% > 0%) |
| Interest Coverage Ratio: 4813 > 6 (EBITDA TTM 3.02b / Interest Expense TTM 605.0k) |
Altman Z'' 9.16
| A: 0.67 (Total Current Assets 14.93b - Total Current Liabilities 2.90b) / Total Assets 18.05b |
| B: 0.53 (Retained Earnings 9.49b / Total Assets 18.05b) |
| C: 0.16 (EBIT TTM 2.91b / Avg Total Assets 17.71b) |
| D: 1.88 (Book Value of Equity 9.50b / Total Liabilities 5.06b) |
| Altman-Z'' Score: 9.16 = AAA |
Beneish M -2.05
| DSRI: 1.03 (Receivables 252.3m/253.4m, Revenue 17.31b/17.95b) |
| GMI: 1.09 (GM 26.75% / 29.09%) |
| AQI: 2.48 (AQ_t 0.15 / AQ_t-1 0.06) |
| SGI: 0.96 (Revenue 17.31b / 17.95b) |
| TATA: 0.02 (NI 2.22b - CFO 1.83b) / TA 18.05b) |
| Beneish M-Score: -2.05 (Cap -4..+1) = BB |
What is the price of PHM shares?
As of February 09, 2026, the stock is trading at USD 135.09 with a total of 1,988,569 shares traded.
Over the past week, the price has changed by +6.31%, over one month by +9.69%, over three months by +12.65% and over the past year by +27.77%.
Over the past week, the price has changed by +6.31%, over one month by +9.69%, over three months by +12.65% and over the past year by +27.77%.
Is PHM a buy, sell or hold?
PulteGroup has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy PHM.
- StrongBuy: 7
- Buy: 3
- Hold: 7
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the PHM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 140.9 | 4.3% |
| Analysts Target Price | 140.9 | 4.3% |
| ValueRay Target Price | 173.8 | 28.7% |
PHM Fundamental Data Overview February 09, 2026
P/E Trailing = 12.1484
P/E Forward = 13.245
P/S = 1.521
P/B = 2.0008
P/EG = 1.204
Revenue TTM = 17.31b USD
EBIT TTM = 2.91b USD
EBITDA TTM = 3.02b USD
Long Term Debt = 1.63b USD (from longTermDebt, last quarter)
Short Term Debt = 532.3m USD (from shortTermDebt, last quarter)
Debt = 2.16b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 154.7m USD (from netDebt column, last quarter)
Enterprise Value = 26.51b USD (26.33b + Debt 2.16b - CCE 1.98b)
Interest Coverage Ratio = 4813 (Ebit TTM 2.91b / Interest Expense TTM 605.0k)
EV/FCF = 15.57x (Enterprise Value 26.51b / FCF TTM 1.70b)
FCF Yield = 6.42% (FCF TTM 1.70b / Enterprise Value 26.51b)
FCF Margin = 9.84% (FCF TTM 1.70b / Revenue TTM 17.31b)
Net Margin = 12.82% (Net Income TTM 2.22b / Revenue TTM 17.31b)
Gross Margin = 26.75% ((Revenue TTM 17.31b - Cost of Revenue TTM 12.68b) / Revenue TTM)
Gross Margin QoQ = 24.78% (prev 27.77%)
Tobins Q-Ratio = 1.47 (Enterprise Value 26.51b / Total Assets 18.05b)
Interest Expense / Debt = 0.01% (Interest Expense 167.0k / Debt 2.16b)
Taxrate = 23.45% (153.6m / 655.2m)
NOPAT = 2.23b (EBIT 2.91b * (1 - 23.45%))
Current Ratio = 5.15 (Total Current Assets 14.93b / Total Current Liabilities 2.90b)
Debt / Equity = 0.17 (Debt 2.16b / totalStockholderEquity, last quarter 12.99b)
Debt / EBITDA = 0.05 (Net Debt 154.7m / EBITDA 3.02b)
Debt / FCF = 0.09 (Net Debt 154.7m / FCF TTM 1.70b)
Total Stockholder Equity = 12.67b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.53% (Net Income 2.22b / Total Assets 18.05b)
RoE = 17.51% (Net Income TTM 2.22b / Total Stockholder Equity 12.67b)
RoCE = 20.36% (EBIT 2.91b / Capital Employed (Equity 12.67b + L.T.Debt 1.63b))
RoIC = 15.10% (NOPAT 2.23b / Invested Capital 14.76b)
WACC = 7.88% (E(26.33b)/V(28.49b) * Re(8.53%) + D(2.16b)/V(28.49b) * Rd(0.01%) * (1-Tc(0.23)))
Discount Rate = 8.53% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.74%
[DCF Debug] Terminal Value 80.18% ; FCFF base≈1.65b ; Y1≈1.86b ; Y5≈2.51b
Fair Price DCF = 228.9 (EV 44.18b - Net Debt 154.7m = Equity 44.03b / Shares 192.3m; r=7.88% [WACC]; 5y FCF grow 14.98% → 2.90% )
EPS Correlation: 34.98 | EPS CAGR: 9.36% | SUE: -0.71 | # QB: 0
Revenue Correlation: 51.22 | Revenue CAGR: 10.70% | SUE: 1.39 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.83 | Chg30d=-0.165 | Revisions Net=-5 | Analysts=13
EPS current Year (2026-12-31): EPS=10.16 | Chg30d=-0.742 | Revisions Net=-6 | Growth EPS=-8.6% | Growth Revenue=-4.8%
EPS next Year (2027-12-31): EPS=11.28 | Chg30d=-1.534 | Revisions Net=-3 | Growth EPS=+11.0% | Growth Revenue=+4.8%
P/E Forward = 13.245
P/S = 1.521
P/B = 2.0008
P/EG = 1.204
Revenue TTM = 17.31b USD
EBIT TTM = 2.91b USD
EBITDA TTM = 3.02b USD
Long Term Debt = 1.63b USD (from longTermDebt, last quarter)
Short Term Debt = 532.3m USD (from shortTermDebt, last quarter)
Debt = 2.16b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 154.7m USD (from netDebt column, last quarter)
Enterprise Value = 26.51b USD (26.33b + Debt 2.16b - CCE 1.98b)
Interest Coverage Ratio = 4813 (Ebit TTM 2.91b / Interest Expense TTM 605.0k)
EV/FCF = 15.57x (Enterprise Value 26.51b / FCF TTM 1.70b)
FCF Yield = 6.42% (FCF TTM 1.70b / Enterprise Value 26.51b)
FCF Margin = 9.84% (FCF TTM 1.70b / Revenue TTM 17.31b)
Net Margin = 12.82% (Net Income TTM 2.22b / Revenue TTM 17.31b)
Gross Margin = 26.75% ((Revenue TTM 17.31b - Cost of Revenue TTM 12.68b) / Revenue TTM)
Gross Margin QoQ = 24.78% (prev 27.77%)
Tobins Q-Ratio = 1.47 (Enterprise Value 26.51b / Total Assets 18.05b)
Interest Expense / Debt = 0.01% (Interest Expense 167.0k / Debt 2.16b)
Taxrate = 23.45% (153.6m / 655.2m)
NOPAT = 2.23b (EBIT 2.91b * (1 - 23.45%))
Current Ratio = 5.15 (Total Current Assets 14.93b / Total Current Liabilities 2.90b)
Debt / Equity = 0.17 (Debt 2.16b / totalStockholderEquity, last quarter 12.99b)
Debt / EBITDA = 0.05 (Net Debt 154.7m / EBITDA 3.02b)
Debt / FCF = 0.09 (Net Debt 154.7m / FCF TTM 1.70b)
Total Stockholder Equity = 12.67b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.53% (Net Income 2.22b / Total Assets 18.05b)
RoE = 17.51% (Net Income TTM 2.22b / Total Stockholder Equity 12.67b)
RoCE = 20.36% (EBIT 2.91b / Capital Employed (Equity 12.67b + L.T.Debt 1.63b))
RoIC = 15.10% (NOPAT 2.23b / Invested Capital 14.76b)
WACC = 7.88% (E(26.33b)/V(28.49b) * Re(8.53%) + D(2.16b)/V(28.49b) * Rd(0.01%) * (1-Tc(0.23)))
Discount Rate = 8.53% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.74%
[DCF Debug] Terminal Value 80.18% ; FCFF base≈1.65b ; Y1≈1.86b ; Y5≈2.51b
Fair Price DCF = 228.9 (EV 44.18b - Net Debt 154.7m = Equity 44.03b / Shares 192.3m; r=7.88% [WACC]; 5y FCF grow 14.98% → 2.90% )
EPS Correlation: 34.98 | EPS CAGR: 9.36% | SUE: -0.71 | # QB: 0
Revenue Correlation: 51.22 | Revenue CAGR: 10.70% | SUE: 1.39 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.83 | Chg30d=-0.165 | Revisions Net=-5 | Analysts=13
EPS current Year (2026-12-31): EPS=10.16 | Chg30d=-0.742 | Revisions Net=-6 | Growth EPS=-8.6% | Growth Revenue=-4.8%
EPS next Year (2027-12-31): EPS=11.28 | Chg30d=-1.534 | Revisions Net=-3 | Growth EPS=+11.0% | Growth Revenue=+4.8%